Publications by authors named "C Guardiani"

Article Synopsis
  • - Berberine (BBR) is a natural molecule with potential to prevent antibiotic resistance in Gram-negative bacteria, but its effectiveness is limited by poor oral bioavailability and absorption in humans.
  • - The study proposes encapsulating BBR in liposomes, which can improve drug delivery and minimize side effects; experimental and computational methods were used to optimize liposome membrane compositions for better BBR encapsulation.
  • - Results show that using negatively charged lipids, such as cholesteryl hemisuccinate, enhances the efficiency of BBR delivery, providing a new strategy for developing effective treatment systems against antibiotic resistance.
View Article and Find Full Text PDF

In the recent years, the number of Point-Of-Care-Tests (POCTs) available for clinical diagnostic has steadily increased. POCTs provide a near-patient testing with the potential to generate a result quickly so that appropriate treatment can be implemented, leading to improved clinical outcomes compared to traditional laboratory testing. Technological advances, such as miniaturization of sensors and improved instrumentation, have revolutionized POCTs, enabling the development of smaller and more accurate devices.

View Article and Find Full Text PDF

Although coveted in applications, few materials expand when subject to compression or contract under decompression, i.e., exhibit negative compressibility.

View Article and Find Full Text PDF

Liquid biopsy is expected to become widespread in the coming years thanks to point of care devices, which can include label-free biosensors. The surface functionalization of biosensors is a crucial aspect that influences their overall performance, resulting in the accurate, sensitive, and specific detection of target molecules. Here, the surface of a microring resonator (MRR)-based biosensor was functionalized for the detection of protein biomarkers.

View Article and Find Full Text PDF

hERG is a voltage-gated potassium channel involved in the heart contraction whose defections are associated with the cardiac arrhythmia Long QT Syndrome type 2. The activator RPR260243 (RPR) represents a possible candidate to pharmacologically treat LQTS2 because it enhances the opening of the channel. However, the molecular detail of its action mechanism remains quite elusive.

View Article and Find Full Text PDF